Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Repeat Dose Safety Study for Compound to Treat Anemia

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: February 9, 2009
Last updated: February 28, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)